Compass Therapeutics, Inc.
CMPX
$5.30
-$0.03-0.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.54% | -36.07% | -52.04% | -54.19% | -12.06% |
| Total Depreciation and Amortization | 3.06% | -20.22% | -21.24% | -21.38% | -23.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.04% | -55.05% | 91.03% | 56.12% | 149.75% |
| Change in Net Operating Assets | -58.72% | 173.59% | 986.36% | 110.04% | 1,917.44% |
| Cash from Operations | -44.66% | 1.83% | -10.02% | 4.90% | 25.84% |
| Capital Expenditure | -- | 84.09% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -121.98% | -427.40% | -198.10% | 383.14% | 143.08% |
| Cash from Investing | -121.98% | -427.92% | -198.10% | 382.70% | 143.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -120.83% | -- | -- | -499.26% | 39.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -431,800.00% | -- | -- | 100.00% |
| Cash from Financing | 1,230.85% | 6,468,150.00% | -100.00% | -104.68% | 40.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -333.00% | 30.01% | -326.04% | -339.53% | 207.81% |